Purchase Order 75N92023P00414

The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute (HHS-NIH-NHLBI) awarded a $731,537.56 purchase order to Bruker Biospin Corp., a subsidiary of Bruker Corporation, to provide a new Bruker 500 MHz FT NMR spectrometer. The contract has a period of performance from March 30, 2023 through December 30, 2023 and utilizes a firm fixed price contract type. The place of performance will be in Billerica, Massachusetts. No applicable...

<p>The National Heart Lung and Blood Institute issued a purchase order to Bruker Biospin Corp on August 27, 2019, for a Biospec Console 9.4 T with a ceiling value of $955,000.00. Performance occurs in Billerica, Massachusetts. The order is firm fixed price with an ultimate completion date of April 30, 2020. The solicitation was posted August 7, 2019, with a due date of August 12, 2019.</p>

This is a $1,394,717.62 firm fixed price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), part of the Department of Health and Human Services' National Institutes of Health, to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC. The contract is for the replacement of an NMR (nuclear magnetic resonance) console NEO800. This procurement falls under the analytical laboratory instrument manufacturing category and involves laboratory equipment and supplies. The...

<p>The National Heart Lung and Blood Institute awarded a purchase order to Bruker Biospin Corp for service agreement support of a NEO 600 MHz NMR cryogenic probe platform, valued at $19,164.86, with an award date of June 30, 2026 and ultimate completion date of June 29, 2027. Work is performed at Bethesda, Maryland. The order is firm fixed price with no set-aside designation.</p>

<p>The Food and Drug Administration awarded a purchase order to Bruker Biospin Corp for an NMR CONSOLE AVANCE NEO 500 MHz with a ceiling value of $732,711.84 on September 18, 2022, with ultimate completion on September 17, 2023. Performance occurs in Billerica, Massachusetts. The order covers procurement of a single advanced nuclear magnetic resonance spectrometer system on a firm fixed price basis with no set-aside designation.</p>

This is a firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Bruker Biospin Corp. The contract is valued at $17,815.02 and will provide a renewed maintenance service contract for an 800 MHz nuclear magnetic resonance (NMR) cryoplatform. This equipment is critical to ensuring continuous access to functional NMR spectrometers for NHLBI's research programs. The award has a completion date of...

The National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $587,061 firm fixed price purchase order to Bruker Biospin Corp. to acquire an Avance Neo 700 MHz NMR console compatible with an existing 700 MHz spectrometer located at NIH's campus in Bethesda, Maryland. The solicitation sought quotes for the NMR equipment upgrade by September 5, 2023, with delivery and installation within six to nine months of award. Evaluation factors included...

This is a firm fixed-price purchase order for $18,710.00 awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC. The contract is for a renewed maintenance agreement for an 800 MHz nuclear magnetic resonance (NMR) cryoplatform to ensure uninterrupted operation of NMR spectrometers that are crucial for the research conducted at the NIH NMR Laboratory. This contract does not...

This is a firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC. The $18,710.00 contract provides a renewed maintenance agreement for a 600 MHz nuclear magnetic resonance (NMR) cryoplatform located at the NHLBI's NMR Laboratory. The equipment is critical for supporting 24/7 access to functional NMR spectrometers, which are...

This $1,526,289.00 firm fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to Bruker Biospin Corp, a for-profit manufacturer, to provide an AVANCE NEO 500 MHz wide-bore nuclear magnetic resonance (NMR) spectrometer and associated hardware and software. The contract was awarded on July 10, 2019 with a completion date of October 14, 2020. This award was not set aside for a specific business...